405 related articles for article (PubMed ID: 22024231)
1. Curative effect comparison between Ivor-Lewis esophagectomy and left transthoracic esophagectomy in treatment of middle thoracic esophagus carcinoma.
Song L; Liu Y; Wang Z; Ren WG; Liu XY
Hepatogastroenterology; 2012 May; 59(115):738-41. PubMed ID: 22024231
[TBL] [Abstract][Full Text] [Related]
2. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
Chen G; Wang Z; Liu XY; Liu FY
Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
[TBL] [Abstract][Full Text] [Related]
4. [The local control of radiotherapy following Ivor-Lewis esophagectomy in the patients with stage II A middle-third thoracic esophageal cancer].
Zhang MY; Wang Z; Liu XY; Chen G; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(14):1048-50. PubMed ID: 19094527
[TBL] [Abstract][Full Text] [Related]
5. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
[TBL] [Abstract][Full Text] [Related]
6. The sweet approach is still worthwhile in modern esophagectomy.
Ma J; Zhan C; Wang L; Jiang W; Zhang Y; Shi Y; Wang Q
Ann Thorac Surg; 2014 May; 97(5):1728-33. PubMed ID: 24650587
[TBL] [Abstract][Full Text] [Related]
7. An audit of surgical outcomes of esophageal squamous cell carcinoma.
Goan YG; Chang HC; Hsu HK; Chou YP
Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
[TBL] [Abstract][Full Text] [Related]
8. Incidence and management of chylothorax after Ivor Lewis esophagectomy for cancer of the esophagus.
Brinkmann S; Schroeder W; Junggeburth K; Gutschow CA; Bludau M; Hoelscher AH; Leers JM
J Thorac Cardiovasc Surg; 2016 May; 151(5):1398-404. PubMed ID: 26936011
[TBL] [Abstract][Full Text] [Related]
9. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
Chen G; Wang Z; Liu XY; Liu FY
Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
[TBL] [Abstract][Full Text] [Related]
10. Short-term outcomes of minimally invasive Ivor-Lewis esophagectomy for esophageal cancer.
Xie MR; Liu CQ; Guo MF; Mei XY; Sun XH; Xu MQ
Ann Thorac Surg; 2014 May; 97(5):1721-7. PubMed ID: 24657031
[TBL] [Abstract][Full Text] [Related]
11. Combined laparoscopic and thoracoscopic Ivor Lewis esophagectomy for esophageal cancer: initial experience from China.
Li H; Hu B; You B; Miao JB; Fu YL; Chen QR
Chin Med J (Engl); 2012 Apr; 125(8):1376-80. PubMed ID: 22613638
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy comparison of two surgical procedures to treat middle thoracic esophageal carcinoma.
Yu Y; Wang Z; Liu XY; Zhu XF; Chen QF
World J Surg; 2010 Feb; 34(2):272-6. PubMed ID: 20041250
[TBL] [Abstract][Full Text] [Related]
13. Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center.
Ott K; Bader FG; Lordick F; Feith M; Bartels H; Siewert JR
Ann Surg Oncol; 2009 Apr; 16(4):1017-25. PubMed ID: 19189186
[TBL] [Abstract][Full Text] [Related]
14. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
[TBL] [Abstract][Full Text] [Related]
15. Early recurrence and death after esophagectomy in patients with esophageal squamous cell carcinoma.
Zhu ZJ; Hu Y; Zhao YF; Chen XZ; Chen LQ; Chen YT
Ann Thorac Surg; 2011 May; 91(5):1502-8. PubMed ID: 21354552
[TBL] [Abstract][Full Text] [Related]
16. Subcarinal node metastasis in thoracic esophageal squamous cell carcinoma.
Liu J; Hu Y; Xie X; Fu J
Ann Thorac Surg; 2012 Feb; 93(2):423-7. PubMed ID: 22178587
[TBL] [Abstract][Full Text] [Related]
17. The use of a tailored surgical technique for minimally invasive esophagectomy.
Javidfar J; Bacchetta M; Yang JA; Miller J; D'Ovidio F; Ginsburg ME; Gorenstein LA; Bessler M; Sonett JR
J Thorac Cardiovasc Surg; 2012 May; 143(5):1125-9. PubMed ID: 22500593
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy comparison of Sweet versus Ivor-Lewis esophagectomy in the treatment of middle-lower esophageal squamous cell carcinoma].
Yang X; Zhan C; Sun F; Chen L; Shi M; Jiang W; Wang Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):979-984. PubMed ID: 27680063
[TBL] [Abstract][Full Text] [Related]
19. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
[TBL] [Abstract][Full Text] [Related]
20. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
